Oral coenzyme Q10 supplementation does not prevent cardiac alterations during a high altitude trek to Everest base camp

High Altitude Medicine and Biology

Volumn 15, Issue 4, 2014, Pages 459-467

  Holloway, Cameron J ^a,b   Murray, Andrew J ^c   Mitchell, Kay ^d,e   Martin, Daniel S ^d   Johnson, Andrew W ^a   Cochlin, Lowri E ^a   Codreanu, Ion ^a   Dhillon, Sundeep ^d   Rodway, George W ^f   Ashmore, Tom ^c   Levett, Denny Z H ^d,e,g   Neubauer, Stefan ^a   Montgomery, Hugh E ^d,h   Grocott, Michael P W ^d,e,g,i   Clarke, Kieran ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f UNIVERSITY OF NEVADA   (United States)

^g UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^h ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

ⁱ University Hospital Southampton NHS Foundation Trust   (United Kingdom)

Author keywords

altitude; cardiac metabolism; Coenzyme Q10; heart function; hypoxia

Indexed keywords

UBIDECARENONE; ANTIOXIDANT; PHOSPHATE; UBIQUINONE; VITAMIN;

ADULT; ALTITUDE; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ECHOCARDIOGRAPHY; ENVIRONMENTAL EXPOSURE; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE METABOLISM; HEART RATE; HEART VOLUME; HUMAN; MALE; MORPHOLOGY; NORMAL HUMAN; OUTCOME ASSESSMENT; ADIPOSE TISSUE; ANALOGS AND DERIVATIVES; ANATOMY AND HISTOLOGY; CELL HYPOXIA; DIASTOLE; DRUG EFFECTS; HEART VENTRICLE; METABOLISM; MIDDLE AGED; MOUNTAINEERING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADIPOSE TISSUE; ADMINISTRATION, ORAL; ADULT; ANTIOXIDANTS; BLOOD PRESSURE; BODY MASS INDEX; CARDIAC VOLUME; CELL HYPOXIA; DIASTOLE; DIETARY SUPPLEMENTS; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOUNTAINEERING; PHOSPHATES; UBIQUINONE; VITAMINS;

EID: 84919694407     PISSN: 15270297     EISSN: 15578682     Source Type: Journal    
DOI: 10.1089/ham.2013.1053     Document Type: Article

References (23)

1. Boussuges A, Molenat F, Burnet H, et al. (2000). Operation Everest III (Comex '97): Modifications of cardiac function secondary to altitude-induced hypoxia. An echocardiographic and Doppler study. Am J Respir Crit Care Med 161: 264-270.
2. Crane FL. (2001). Biochemical functions of Coenzyme Q10. J Am Coll Nutr 20: 591-598.
3. Echtay KS, Murphy MP, Smith RA, Talbot DA, and Brand MD. (2002). Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem 277: 47129-47135.
4. Edwards LM, Murray AJ, Tyler DJ, et al. (2010). The effect of high-altitude on human skeletal muscle energetics: P-MRS results from the Caudwell Xtreme Everest expedition. PLoS One 5: e10681.
5. Firstenberg MS, Levine BD, Garcia MJ, et al. (2000). Relationship of echocardiographic indices to pulmonary capillary wedge pressures in healthy volunteers. J Am Coll Cardiol 36: 1664-1669.
6. Guzy RD, Schumacker PT. (2006). Oxygen sensing by mitochondria at complex III: The paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91: 807-819.
7. Heather LC, Cole MA, Tan JJ, et al. (2012). Metabolic adaptation to chronic hypoxia in cardiac mitochondria. Basic Res Cardiol 107: 268.
8. Holloway CJ, Montgomery HE, Murray AJ, et al. (2011). Cardiac response to hypobaric hypoxia: Persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp. FASEB J 25: 792-796.
9. Howald H, and Hoppeler H. (2003). Performing at extreme altitude: Muscle cellular and subcellular adaptations. Eur J Appl Physiol 90: 360-364.
10. Hudsmith LE, Petersen SE, Tyler DJ, et al. (2006). Determination of cardiac volumes and mass with FLASH and SSFP cine sequences at 1.5 vs. 3 Tesla: A validation study. J Magn Reson Imaging 24: 312-318.
11. Karamitsos TD, Hudsmith LE, Selvanayagam JB, Neubauer S, and Francis JM. (2007). Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. J Cardiovasc Magn Reson 9: 777-783.
12. Kjaergaard J, Snyder EM, Hassager C, Olson TP, Oh JK, and Johnson BD. (2006). The effect of 18 h of simulated high altitude on left ventricular function. Eur J Appl Physiol 98: 411-418.
13. Levett DZ, Fernandez BO, Riley HL, et al. (2011). The role of nitrogen oxides in human adaptation to hypoxia. Sci Rep 1: 109.
14. Levett DZ, Martin DS, Wilson MH, et al. (2010). Design and conduct of Caudwell Xtreme Everest: An observational cohort study of variation in human adaptation to progressive environmental hypoxia. BMC Med Res Methodol 10: 98.
15. Levett DZ, Radford EJ, Menassa DA, et al. (2012). Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest. FASEB J 26: 1431-1441.
16. Mizuno K, Tanaka M, Nozaki S, et al. (2008). Antifatigue effects of Coenzyme Q10 during physical fatigue. Nutrition 24: 293-299.
17. Murray AJ. (2009). Metabolic adaptation of skeletal muscle to high altitude hypoxia: How new technologies could resolve the controversies. Genome Med 1: 117.
18. Murray AJ. (2013). Of mice and men (and muscle mitochondria). Exp Physiol 98: 879-880.
19. Murray AJ, Knight NS, Little SE, Cochlin LE, Clements M, and Clarke K. (2011). Dietary long-chain, but not medium-chain, triglycerides impair exercise performance and uncouple cardiac mitochondria in rats. Nutr Metab (Lond) 8: 55.
20. Poon WW, Do TQ, Marbois BN, and Clarke CF. (1997). Sensitivity to treatment with polyunsaturated fatty acids is a general characteristic of the ubiquinone-deficient yeast coq mutants. Mol Aspects Med 18 Suppl: S121-127.
21. Semenza GL. (2007). Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007: cm8.
22. Tian R, Nascimben L, Ingwall JS, and Lorell BH. (1997). Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. Circulation 96: 1313-1319.
23. Tyler DJ, Emmanuel Y, Cochlin LE, et al. (2009). Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3 T. NMR Biomed 22: 405-413.